Harris A. Gelbard

Center for Neural Development and Disease, University of Rochester

Research Area

Biography

Harris A. Gelbard has not added Biography.
If you are Harris A. Gelbard and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 64	2010

Other Publications

Article	Year
Tumor necrosis factor-alpha in normal and diseased brain: Conflicting effects via intraneuronal receptor crosstalk? Journal of neurovirology\| PubMed ID: 12476354	2002
Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology\| PubMed ID: 12890621	2003
Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 14534250	2003
Synapses and Sisyphus: life without paraplegin. The Journal of clinical investigation\| PubMed ID: 14722610	2004
Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. Journal of neurovirology\| PubMed ID: 14982736	2004
Immunohistochemical assessment of fractalkine, inflammatory cells, and human herpesvirus 7 in human salivary glands. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society\| PubMed ID: 15100244	2004
Activation of adenosine A2A receptor protects sympathetic neurons against nerve growth factor withdrawal. Journal of neuroscience research\| PubMed ID: 15211592	2004
Antioxidants are required during the early critical period, but not later, for neuronal survival. Journal of neuroscience research\| PubMed ID: 15389829	2004
Neuroprotective strategies for HIV-1 associated dementia. Neurotoxicity research\| PubMed ID: 15639783	2004
HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15778398	2005
Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 16162919	2005
Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor. The Journal of clinical investigation\| PubMed ID: 16276420	2005
Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16785569	2006
Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. The European journal of neuroscience\| PubMed ID: 16817865	2006
HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeost... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17202348	2007
Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17312171	2007
Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology\| PubMed ID: 18040788	2006
Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology\| PubMed ID: 18040831	2007
The phospholipid mediator platelet-activating factor mediates striatal synaptic facilitation. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology\| PubMed ID: 18040844	2007
HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PloS one\| PubMed ID: 19009018	2008
Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment. Journal of neurovirology\| PubMed ID: 19306230	2009
Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders. Journal of neuroimmunology\| PubMed ID: 19541372	2009
Neuroprotective activities of CEP-1347 in models of neuroAIDS. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19966207	2010
Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth. AIDS (London, England)\| PubMed ID: 20539091	2010
Two-photon NADH imaging exposes boundaries of oxygen diffusion in cortical vascular supply regions. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\| PubMed ID: 20859293	2011
Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 20880503	2010
Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 20962236	2010
Ablation of mixed lineage kinase 3 (Mlk3) does not inhibit ototoxicity induced by acoustic trauma or aminoglycoside exposure. Hearing research\| PubMed ID: 20971179	2010
Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 21368026	2011
Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. BioTechniques\| PubMed ID: 21486251	2011
HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PloS one\| PubMed ID: 21912650	2011